[1]Yabana T, Arimura Y, Tanaka H,et al.Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity.J Pathol. 2009;218(3):350-359.
[2]Pittenger MF, Mackay AM, Beck SC,et al.Multilineage potential of adult human mesenchymal stem cells.Science. 1999;284(5411):143-147.
[3]Friedenstein AJ, Chailakhyan RK, Gerasimov UV.Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers.Cell Tissue Kinet. 1987; 20(3):263-272.
[4]Halleux C, Sottile V, Gasser JA,et al.Multi-lineage potential of human mesenchymal stem cells following clonal expansion.J Musculoskelet Neuronal Interact. 2001;2(1):71-76.
[5]Muraglia A, Cancedda R, Quarto R.Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model.J Cell Sci. 2000;113 ( Pt 7): 1161-1166.
[6]Sarrazin S, Mossadegh-Keller N, Fukao T,et al.MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells.Cell. 2009;138(2):300-313.
[7]Oyama Y, Craig RM, Traynor AE,et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease.Gastroenterology. 2005;128(3): 552-563.
[8]García-Olmo D, García-Arranz M, Herreros D,et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation.Dis Colon Rectum. 2005;48(7):1416-1423.
[9]Drakos PE, Nagler A, Or R.Case of Crohn's disease in bone marrow transplantation.Am J Hematol. 1993;43(2):157-158.
[10]Kashyap A, Forman SJ.Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease.Br J Haematol. 1998;103(3):651-652.
[11]Lopez-Cubero SO, Sullivan KM, McDonald GB.Course of Crohn's disease after allogeneic marrow transplantation. Gastroenterology. 1998;114(3):433-440.
[12]Ditschkowski M, Einsele H, Schwerdtfeger R,et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation. 2003;75(10): 1745-1747.
[13]Anumakonda V, Hayee B, Chung-Faye G.Remission and relapse of Crohn's disease following autologous haematopoietic stem cell transplantation for non-Hodgkin's lymphoma.Gut. 2007;56(9):1325.
[14]赖洁莹,李瑜元,魏亚明,等.骨髓造血细胞移植治疗克罗恩病的动物研究[J].广州医学院学报,2006,34(6):1-4.
[15]Wei Y, Nie Y, Lai J,et al.Comparison of the population capacity of hematopoietic and mesenchymal stem cells in experimental colitis rat model.Transplantation. 2009;88(1):42-48.
[16]魏亚明,聂玉强,李瑜元,等.炎症性肠病及其干细胞移植再生修复[J].世界华人消化杂志,2006,14(13):1314-1317.
[17]李瑜元,聂玉强,赖洁莹,等.干细胞移植对大鼠实验性结肠炎的研究[J].中华消化杂志,2008,28(6):364-368.
[18]Hollenbach E, Vieth M, Roessner A,et al.Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease.J Biol Chem. 2005;280(15):14981-14988.
[19]Golub TR, Slonim DK, Tamayo P,et al.Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.Science. 1999;286(5439):531-537.
[20]Snijders AM, Meijer GA, Brakenhoff RH,et al.Microarray techniques in pathology: tool or toy.Mol Pathol. 2000;53(6): 289-294.
[21]He XW, He XS, Lian L,et al.Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice.Dig Dis Sci. 2012;57(12): 3136-3144.
[22]陈隆典,欧阳建,张晓琦,等.自体造血干细胞移植治疗难治性炎症性肠病10例回顾与随访[J].中华消化杂志,2008,28(7):476-479.
[23]Yamamoto T, Fujiwara K, Yoshida M,et al.Therapeutic effect of kakkonto in a mouse model of food allergy with gastrointestinal symptoms.Int Arch Allergy Immunol. 2009; 148(3):175-185.
[24]Schouten B, van Esch BC, Hofman GA,et al.Acute allergic skin reactions and intestinal contractility changes in mice orally sensitized against casein or whey.Int Arch Allergy Immunol. 2008;147(2):125-134.
[25]Te Velde AA, Pronk I, de Kort F,et al.Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2. Eur J Gastroenterol Hepatol. 2008; 20(6):555-560.
[26]Pemberton AD, Brown JK, Wright SH,et al.The proteome of mouse mucosal mast cell homologues: the role of transforming growth factor beta1.Proteomics. 2006;6(2):623-631.
[27]Gallwitz M, Hellman L.Rapid lineage-specific diversification of the mast cell chymase locus during mammalian evolution.Immunogenetics. 2006;58(8):641-654.
[28]Gallwitz M, Enoksson M, Hellman L.Expression profile of novel members of the rat mast cell protease (rMCP)-2 and (rMCP)-8 families, and functional analyses of mouse mast cell protease (mMCP)-8.Immunogenetics. 2007;59(5):391-405.
[29]Takemoto S, Yamamoto A, Tomonaga S,et al.Magnesium deficiency induces the emergence of mast cells in the liver of rats.J Nutr Sci Vitaminol (Tokyo). 2013;59(6):560-563.
[30]Rinaldi M, Dreesen L, Hoorens PR,et al.Infection with the gastrointestinal nematode Ostertagia ostertagi in cattle affects mucus biosynthesis in the abomasum.Vet Res. 2011;42:61.
[31]Oshiumi H, Matsumoto M, Seya T.Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I.J Biochem. 2012;151(1):5-11.
[32]Asahina Y, Izumi N, Hirayama I,et al.Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response.Gastroenterology. 2008; 134(5):1396-1405.
[33]Kawasaki H, Yoshida T, Horiguchi K,et al.Characterization of anoikis-resistant cells in mouse colonic epithelium.J Vet Med Sci. 2013;75(9):1173-1180.
[34]Ziskin JL, Dunlap D, Yaylaoglu M,et al. In situ validation of an intestinal stem cell signature in colorectal cancer.Gut. 2013;62(7):1012-1023.
[35]Gersemann M, Becker S, Nuding S,et al.Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD.J Crohns Colitis. 2012;6(4):425-434.
[36]Yu L, Wang L, Chen S.Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma. 2011;58(1):9-13.
[37]Zhang J, Liu WL, Tang DC,et al.Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development.Gene. 2002;283(1-2):83-93.
[38]VanDussen KL, Carulli AJ, Keeley TM,et al. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.Development. 2012;139(3):488- 497.
[39]Dooley TP, Curto EV, Reddy SP, et al.Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.Inflamm Bowel Dis. 2004;10(1):1-14.
[40]常晓彤,王振辉,付小兵.内源性肝脂肪酸结合蛋白基因与肠道干细胞分化发育的关系[J].中国临床康复,2003,7(14):2022-2023.
[41]Goretsky T, Dirisina R, Sinh P,et al.p53 mediates TNF-induced epithelial cell apoptosis in IBD.Am J Pathol. 2012;181(4):1306-1315.
[42]Lo Furno D, Graziano AC, Caggia S,et al.Decrease of apoptosis markers during adipogenic differentiation of mesenchymal stem cells from human adipose tissue. Apoptosis. 2013;18(5):578-588.
[43]Mei Y, Bian C, Li J,et al.miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation.J Cell Biochem. 2013;114(6):1374-1384.
[44]Monaco E, Bionaz M, Rodriguez-Zas S, et al.Transcriptomics comparison between porcine adipose and bone marrow mesenchymal stem cells during in vitro osteogenic and adipogenic differentiation.PLoS One. 2012;7(3):e32481. |